Uptake of bowel cancer screening (BCS) is a complex multifactorial problem. This article seeks to outline the current BCS screening modalities. It examines the drivers and barriers to BCS uptake. Finally, it aims to provide practical evidence-based guidance on how best to increase BCS uptake in practice.
Get full access to this article
View all access options for this article.
References
1.
BaschCWolfRBrouseC, et al. (2006) Telephone outreach to increase colorectal cancer screening in an urban minority population. American Journal of Public Health96(12): 2246–2253. DOI: 10.2105/AJPH.2005.067223.
2.
CameronKPersellDBrownT, et al. (2011) Patient outreach to promote colorectal cancer screening among patients with an expired order for colonoscopy: A randomized controlled trial. Archives of Internal Medicine171(7): 642–646. DOI: 10.1001/archinternmed.2010.468.
ChappleAZieblandSHewitsonP, et al. (2008) What affects the uptake of screening for bowel cancer using a faecal occult blood test (FOBt): A qualitative study. Social Science & Medicine66(12): 2425–2435. DOI: 10.1016/j.socscimed.2008.02.009.
6.
ColeSYoungGByrneD, et al. (2002) Participation in screening for colorectal cancer based on a faecal occult blood test is improved by endorsement by the primary care practitioner. Journal of Medical Screening9(4): 147–152. DOI: /10.1136/jms.9.4.147.
7.
FloudSBarnesIVerfürdenM, et al. (2017) Disability and participation in breast and bowel cancer screening in England: A large prospective study. British Journal of Cancer117(11): 1711–1714. DOI: 10.1038/bjc.2017.331.
8.
HallNRubinGDobsonC, et al. (2015) Attitudes and beliefs of non-participants in a population-based screening programme for colorectal cancer. Health Expectations: An International Journal of Public Participation in Health Care and Health Policy18(5): 1645–1657. DOI: 10.1111/hex.12157.
9.
HewitsonPGlasziouPWatsonE, et al. (2008) Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): An update. American Journal of Gastroenterology103(6): 1541–1549. DOI: 10.1111/j.1572-0241.2008.01875.x.
10.
HewitsonPWardAHeneghanC, et al. (2011) Primary care endorsement letter and a patient leaflet to improve participation in colorectal cancer screening: Results of a factorial randomised trial. British Journal of Cancer105(4): 475–480. DOI: 10.1038/bjc.2011.255.
11.
HolLWildschutJvan BallegooienM (2009) Screening for colorectal cancer: Random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. British Journal of Cancer100(7): 1103–1110.
12.
KobayashiLWardleJvon WagnerC (2014) Limited health literacy is a barrier to colorectal cancer screening in England: Evidence from the English Longitudinal Study of Ageing. Preventive Medicine61: 100–105. DOI: 10.1016/j.ypmed.2013.11.012.
13.
McCafferyKWardleJWalleraJ (2003) Knowledge, attitudes, and behavioral intentions in relation to the early detection of colorectal cancer in the United Kingdom. Preventive Medicine36(5): 525–535. DOI: 10.1016/S0091-7435(03)00016-1.
14.
MilesARainbowSvon WagnerC (2011) Cancer fatalism and poor self-rated health mediate the association between socioeconomic status and uptake of colorectal cancer screening in England. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology20(10): 2132–2140. DOI: 10.1158/1055-9965.EPI-11-0453.
15.
MousavinezhadMMajdzadehRAkbari SariA, et al. (2016) The effectiveness of FOBT vs. FIT: A meta-analysis on colorectal cancer screening test. Medical Journal of the Islam Republic of Iran30: 366.
OsbornDHorsfallLHassiotisA, et al. (2012) Access to cancer screening in people with learning disabilities in the UK: Cohort study in the health improvement network, a primary care research database. PLoS One7(8): e43841DOI: 10.1371/journal.pone.0043841.
21.
PalmerCThomasMvon WagnerC, et al. (2014) Reasons for non-uptake and subsequent participation in the NHS bowel cancer screening programme: A qualitative study. British Journal of Cancer110(7): 1705–1711. DOI: 10.1038/bjc.2014.125.
22.
PowerEMilesAvon WagnerC, et al. (2009) Uptake of colorectal cancer screening: System, provider and individual factors and strategies to improve participation. Future Oncology (London, England)5(91371–1388. DOI: 10.2217/fon.09.134.
RaineRDuffySWWardleJ, et al. (2016) Impact of general practice endorsement on the social gradient in uptake in bowel cancer screening. British Journal of Cancer114(3): 321–326. DOI: 10.1038/bjc.2015.413.
ShankaranVMcKoyJDandadeN, et al. (2007) Costs and cost-effectiveness of a low-intensity patient-directed intervention to promote colorectal cancer screening. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology25(33): 5248–5253. DOI: 10.1200/JCO.2007.13.4098.
27.
ShanklemanJMassatNKhagramL, et al. (2014) Evaluation of a service intervention to improve awareness and uptake of bowel cancer screening in ethnically-diverse areas. British Journal of Cancer111(7): 1440–1447. DOI: 10.1038/bjc.2014.363.
28.
SteeleRKostourouIMcClementsP (2010) Effect of gender, age and deprivation on key performance indicators in a FOBT-based colorectal screening programme. Journal of Medical Screening17(2): 68–74. DOI: 10.1258/jms.2010.009120.
Von WagnerCBaioGRaineR, et al. (2011) Inequalities in participation in an organized national colorectal cancer screening programme: Results from the first 2.6 million invitations in England. International Journal of Epidemiology40(3): 712–718. DOI: 10.1093/ije/dyr008.
31.
Von WagnerCSemmlerCGoodA, et al. (2009) Health literacy and self-efficacy for participating in colorectal cancer screening: The role of information processing. Patient Education and Counseling75(3): 352–357. DOI: 10.1016/j.pec.2009.03.015.
32.
WardleJSuttonSWilliamsonS, et al. (2000) Psychosocial influences on older adults’ interest in participating in bowel cancer screening. Preventive Medicine31(4): 323–334. DOI: 10.1006/pmed.2000.0725.
33.
WardleJvon WagnerCKralj-HansI, et al. (2016) Effects of evidence-based strategies to reduce the socioeconomic gradient of uptake in the English NHS bowel cancer screening programme (ASCEND): Four cluster-randomised controlled trials. Lancet387(10020): 751–759. DOI: 10.1016/S0140-6736(15)01154-X.
